- Home
- PCTY vs RADX Comparison
PCTY vs RADX Comparison
Compare PCTY & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCTY
- RADX
- Stock Information
- Founded
- PCTY 1997
- RADX 2021
- Country
- PCTY United States
- RADX Australia
- Employees
- PCTY N/A
- RADX N/A
- Industry
- PCTY Computer Software: Prepackaged Software
- RADX
- Sector
- PCTY Technology
- RADX
- Exchange
- PCTY Nasdaq
- RADX NYSE
- Market Cap
- PCTY 11.7B
- RADX 38.4M
- IPO Year
- PCTY 2014
- RADX N/A
- Fundamental
- Price
- PCTY $182.79
- RADX $5.40
- Analyst Decision
- PCTY Strong Buy
- RADX Strong Buy
- Analyst Count
- PCTY 17
- RADX 1
- Target Price
- PCTY $232.65
- RADX $15.00
- AVG Volume (30 Days)
- PCTY 431.5K
- RADX 478.8K
- Earning Date
- PCTY 05-01-2025
- RADX 02-26-2025
- Dividend Yield
- PCTY N/A
- RADX N/A
- EPS Growth
- PCTY 31.57
- RADX N/A
- EPS
- PCTY 3.89
- RADX N/A
- Revenue
- PCTY $1,498,504,000.00
- RADX $204,609.00
- Revenue This Year
- PCTY $13.80
- RADX N/A
- Revenue Next Year
- PCTY $10.46
- RADX N/A
- P/E Ratio
- PCTY $47.96
- RADX N/A
- Revenue Growth
- PCTY 15.96
- RADX N/A
- 52 Week Low
- PCTY $129.94
- RADX $3.55
- 52 Week High
- PCTY $223.80
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- PCTY 34.84
- RADX N/A
- Support Level
- PCTY $183.98
- RADX N/A
- Resistance Level
- PCTY $203.70
- RADX N/A
- Average True Range (ATR)
- PCTY 6.28
- RADX 0.00
- MACD
- PCTY -2.38
- RADX 0.00
- Stochastic Oscillator
- PCTY 9.67
- RADX 0.00
About PCTY Paylocity Holding Corporation
Paylocity is a provider of payroll and human capital management, or HCM, solutions servicing small- to midsize clients in the United States. The company was founded in 1997 and targets businesses with 10 to 5,000 employees and services about 39,000 clients as of fiscal 2024. Alongside core payroll services, Paylocity offers HCM solutions such as time and attendance and recruiting software, as well workplace collaboration and communication tools.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.